Scientists integrated single-cell transcriptome, single-nuclei chromatin accessibility, and cell-type specific 3D genome profiles from human islets and identified type II diabetes-associated β-cell heterogeneity at both transcriptomic and epigenomic levels.
[Nature Communications]